 Most microtubule inhibitors affect both cancerous and healthy cells, requiring lower doses to avoid severe side effects.Because photostatins are inactive in the absence of light, they only affect cells that are illuminated.Focusing light on tumors directs their activities to appropriate targets with fewer side effects.